RFK Jr. Right About Kid Vaccines
Digest more
2h
Health on MSNYou Can Now Give Yourself a Flu Vaccine At Home. What You Need to Know Before Trying
This fall, FluMist, a flu vaccine in nasal spray form, is available for home delivery. But is it better than the flu shot? Experts weigh in.
The American Academy of Pediatrics had earlier urged parents to get young children vaccinated against Covid — pushing back against the health secretary’s stance.
FluMist is now approved by the U.S. Food and Drug Administration for use at home, and it can be ordered online. It is the only nasal spray flu vaccine in the U.S. FluMist can be self-administered by adults under 50, and can be given to children as young as 2.
The American Academy of Pediatrics issued vaccine recommendations that differ from U.S. Centers for Disease Control guidelines for the first time in 30 years.
2don MSN
Leading pediatrician group recommends COVID vaccine for infants, toddlers in contrast with RFK Jr.
The American Academy of Pediatrics said on Tuesday that children ages 6 months to 23 months should receive a COVID-19 vaccine, in contrast with federal health officials.
The AAP published its own vaccine schedule in a break from federal guidance. HHS secretary RFK Jr. took to social media to respond.
Senior author Elias Sayour, M.D., Ph.D., a UF Health pediatric oncologist, said the results reveal a potential new treatment path — an alternative to surgery, radiation, and chemotherapy — with broad implications for battling many types of treatment-resistant tumors.
Fox News senior national correspondent Rich Edson reports on Secretary of Health and Human Services RFK Jr.'s battle against the American Academy of Pediatrics over COVID vaccine information and recommendations on 'Special Report.
Multiple scientists and doctors have spoken out against this decision, including infectious diseases expert Dr. Thomas A. Russo, who told Newsweek that mRNA vaccines "will be critical when the next, inevitable infectious diseases crisis rears its ugly head."
While phase 1 data suggest the novel vaccine can boost immunity and reduce relapse in pancreatic and colorectal cancer, experts remain cautious at this initial stage.
Shares of Dynavax rose after the company released positive results from a trial of its shingles vaccine tested against current Shingles vaccine Shingrix. The stock was up 6.7% to $11.12 but is still down 13% so far this year.
Lafayette, said Wednesday he will seek to strip federal funding from the New Orleans Health Department following a social media post about COVID-19 immunizations for children.